{
	"answerText": "VEGF-A [or vascular endothelial growth factor][10] A key factor in the potency of the 165, 189 and 206 splice variants of VEGF-A is the presence of domains that bind to this molecule. Injections of this anticoagulant, which is not available orally like warfarin, are used to decrease the threat of blood clots.",
	"prompts": [],
	"heading": "ACF Regionals |2013 | Editors 1 | 2 | Science | Biology | College",
	"subject": "Science",
	"level": "College",
	"question": "Question: Expression of this mitogen is increased by hypoxia, activated oncogenes and by a number of cytokines. For 10 points each: [10] Identify this growth factor that, in vivo, induces angiogenesis and permeabilization of blood vessels, as well as regulating vasculogenesis.",
	"answers": [
		"VEGF-A",
		"vascular",
		"endothelial",
		"growth",
		"factor",
		"10",
		"A",
		"key",
		"in",
		"potency",
		"165",
		"189",
		"and",
		"206",
		"splice",
		"variants",
		"presence",
		"domains",
		"that",
		"bind",
		"to",
		"this",
		"molecule",
		"Injections",
		"anticoagulant",
		"which"
	]
}